지도부에 새로 오신 두 주요 인물을 소개하게 되어서 기쁩니다! William Wesley ‘Wes’ Pringle 씨가 최고경영자(CEO) 직책에, Hiroyuki Yoshimoto 씨가 회장 겸 최고 운영 책임자로 임명되었습니다. 언론 발표를 통해 자세한 정보를 알아보세요.
Together with the University of Montreal’s School of Optometry and the Centre interdisciplinaire de recherche sur le cerveau et l l’apprentissage (CIRCA), we celebrated the inauguration of the campus’ new Evident Discovery Center! Learn more in the press release.
지도부에 새로 오신 두 주요 인물을 소개하게 되어서 기쁩니다! William Wesley ‘Wes’ Pringle 씨가 최고경영자(CEO) 직책에, Hiroyuki Yoshimoto 씨가 회장 겸 최고 운영 책임자로 임명되었습니다. 언론 발표를 통해 자세한 정보를 알아보세요.
Together with the University of Montreal’s School of Optometry and the Centre interdisciplinaire de recherche sur le cerveau et l l’apprentissage (CIRCA), we celebrated the inauguration of the campus’ new Evident Discovery Center! Learn more in the press release.
Evident Corporation (“Evident”) today announced the appointment of Eric Anderson, a current member of the Office of the CEO, as Interim CEO. He takes on the responsibilities of Yoshitake Saito, who assumes the role of Chairman effective immediately.
On February 8, we’re hosting a virtual organoid conference that brings experts together from around the Asia-Pacific region to discuss their research. Learn more about the conference in this press release.
To meet the challenges of wind power gearbox inspections—such as cramped quarters, oil environments, and hard-to-reach areas—we created the compact, powerful IPLEX G Lite-W videoscope. Learn more in the press release.
Evident announced the opening of its new Asia-Pacific (APAC) headquarters in Singapore, marking its ongoing commitment to expand its business and operations in the APAC region.
Sakura Finetek과 Olympus Corporation의 완전자회사이자 현미경 및 이미징 솔루션 분야의 글로벌 리더인 Evident Scientific이 미주 지역에 해부병리학 슬라이드 준비 및 고해상도 디지털 스캐닝을 위한 완전한 워크플로 솔루션을 제공하기 위해 협업한다고 금일 발표했다.
미국 매사추세츠주 월섬(WALHAM, 2022년 8월 29일) 올림푸스 주식회사의 전액 출자 자회사 에비던트는 일본 디지털 병리학회 제20차 연차총회에서 AI 기반 병리학 진단 도구를 만들기 위해 진행 중인 공동 연구 프로그램의 최신 결과를 발표했습니다. 결과는 개발 중인 진단 도구가 AI 검출을 7가지 유형의 위암으로 확장하는 데 성공했음을 보여주며, 다양한 병리학적 응용에 대한 다재다능성을 강조합니다.
Olympus Corporation (“Olympus”) and EVIDENT Co., Ltd. ("Evident"), a wholly-owned subsidiary of Olympus announced today that Olympus concluded a definitive agreement with Bain Capital Private Equity, LP (“Bain Capital”), regarding the transfer of Evident. Based on this agreement, all shares of Evident will be transferred to Bain Capital on January 4, 2023, subject to regulatory approvals and closing conditions.
Our new SZX-AR1 augmented reality system easily retrofits to existing SZX series stereo microscopes to simplify complex microscope-based manufacturing tasks. Get all the details in the press release.
New PRECiV software turns any manual microscope into a complete imaging and measurement platform. Learn about the software’s benefits and features in the press release.
Our new OmniScan X3 64 flaw detector delivers improved power and performance to our field-proven phased array instruments. Read the press release to get all the details.
Earlier this year, Olympus announced its plans to reorganize the Scientific Solutions Division into a self-sustainable company. This reorganization will enable the Scientific Solutions business a greater level of autonomy and agility to respond more quickly and with more flexibility to our industrial and life science customers’ needs.
